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Records not meeting 
criteria
(n = 683)
Inclusion criteria: Phase II, Phase II/III, Phase III Clinical Trial of Investigational Medicinal 
Product (CTIMP) assessing potential disease modifying treatment in Amyotrophic lateral 
sclerosis. Registered, completed or published from 1 Jan 2008 to 9 April 2019.
